Latest Breaking News On - End to technology - Page 1 : comparemela.com

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSouth koreaExperte carsten storkPlanegg martinsriedZwei rohstoff chancenPamela keckEuropean patent officePrime standardEnd to technologyEnd to platform

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T

Planegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid

United statesSouth koreaNew yorkPamela keckPlanegg martinsriedEuropean patent officePrime standardEnd to technologyEnd to platform

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell Receptor

Planegg/Martinsried, May 2, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announces today that the.

South koreaNew yorkUnited statesPamela keckPlanegg martinsriedEuropean patent officePrime standardEnd to technologyEnd to platform